Clinical Trials on Heart Failure With Reduced Ejection Fraction NYHA Class III-IV in Finland
Total 13 results
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Hospital District of Helsinki and UusimaaOulu University Hospital; University of HelsinkiRecruitingCoronary Artery Disease | Ischemic Heart Disease | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Ischemic Cardiomyopathy | Heart Failure NYHA Class IVFinland
-
Memorial Hospital of Rhode IslandUniversity of California, San Diego; National Heart, Lung, and Blood Institute... and other collaboratorsUnknownHeart Failure | Physical Activity | Elderly | Heart Failure With Reduced Ejection Fraction | Heart Failure With Normal Ejection Fraction | Women | Strength TrainingUnited States
-
The University of Hong KongChinese University of Hong Kong; Novartis Pharmaceuticals; Biofourmis Singapore...Active, not recruitingHeart Failure With Reduced Ejection FractionHong Kong
-
Novartis PharmaceuticalsCompletedHeart Failure With Reduced Ejection FractionHungary, Spain, Italy, United States, Germany, United Kingdom, Turkey, Slovakia, Bulgaria, Finland, Puerto Rico
-
Novartis PharmaceuticalsCompletedChronic Heart Failure With Reduced Ejection FractionBelgium, Estonia, Denmark, Greece, United Kingdom, Germany, Latvia, Lithuania, Spain, Netherlands, Bulgaria, Finland, Poland, Czechia, Iceland, Sweden, France, Ireland, Norway
-
Novartis PharmaceuticalsTerminatedHeart Failure With Reduced Ejection FractionChina, Germany, United States, Colombia, Korea, Republic of, Romania, South Africa, Canada, Belgium, Estonia, Hungary, Italy, Russian Federation, Taiwan, Turkey, United Kingdom, Spain, France, Netherlands, Hong Kong, Bulgaria, Israel and more
-
Novartis PharmaceuticalsCompletedChronic Heart Failure With Reduced Ejection FractionIndia, Romania, Belgium, Czechia, Estonia, Hungary, Russian Federation, Taiwan, United Kingdom, Spain, Israel, Thailand, Canada, Korea, Republic of, United States, Bulgaria, Denmark, Netherlands, Philippines, Lithuania, Germany, T... and more
-
AstraZenecaCompletedChronic Heart Failure With Reduced Ejection Fraction (HFrEF)United States, Canada, Denmark, United Kingdom, Czechia, Vietnam, Germany, Brazil, India, China, Japan, Taiwan, Netherlands, Bulgaria, Slovakia, Hungary, Poland, Russian Federation, Argentina, Sweden
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection FractionChina, Germany, United States, Colombia, South Africa, Italy, Austria, Belgium, Croatia, Romania, Taiwan, Japan, Netherlands, Denmark, France, Israel, Spain, Switzerland, Korea, Republic of, Argentina, Canada, United Kingdom, Bulgaria, Gree... and more
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States, Canada
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, Canada, Belgium, Czechia, Hungary, Taiwan, Vietnam, Mexico, Peru, China, Japan, Bulgaria, Spain, Brazil, Saudi Arabia, Netherlands, Romania, Russian Federation, Poland, Argentina
-
Ancora Heart, Inc.RecruitingDilated Cardiomyopathy | Heart Failure With Reduced Ejection Fraction (HFrEF)United States, France, Netherlands, Czechia, Belarus, Belgium, Serbia